• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肾脏病和心脏中的动静脉瘘:一种新型大鼠模型的生理学、组织学和转录组学特征。

Arteriovenous Fistulae in Chronic Kidney Disease and the Heart: Physiological, Histological, and Transcriptomic Characterization of a Novel Rat Model.

机构信息

Department of Cardiovascular Sciences KU Leuven Leuven Belgium.

MoSAIC, Biomedical MRI, Department of Imaging and Pathology KU Leuven Leuven Belgium.

出版信息

J Am Heart Assoc. 2022 Oct 18;11(20):e027593. doi: 10.1161/JAHA.122.027593. Epub 2022 Oct 7.

DOI:10.1161/JAHA.122.027593
PMID:36205249
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9673660/
Abstract

Background Arteriovenous fistulae (AVFs) are the gold standard for vascular access in those requiring hemodialysis but may put an extra hemodynamic stress on the cardiovascular system. The complex interactions between the heart, kidney, and AVFs remain incompletely understood. Methods and Results We characterized a novel rat model of five-sixths partial nephrectomy (NX) and AVFs. NX induced increases in urea, creatinine, and hippuric acid. The addition of an AVF (AVF+NX) further increased urea and a number of uremic toxins such as trimethylamine N-oxide and led to increases in cardiac index, left and right ventricular volumes, and right ventricular mass. Plasma levels of uremic toxins correlated well with ventricular morphology and function. Heart transcriptomes identified altered expression of 8 genes following NX and 894 genes following AVF+NX, whereas 290 and 1431 genes were altered in the kidney transcriptomes, respectively. Gene ontology and Kyoto Encyclopedia of Genes and Genomes analysis revealed gene expression changes related to cell division and immune activation in both organs, suppression of ribosomes and transcriptional activity in the heart, and altered renin-angiotensin signaling as well as chronodisruption in the kidney. All except the latter were worsened in AVF+NX compared with NX. Conclusions Inflammation and organ dysfunction in chronic kidney disease are exacerbated following AVF creation. Furthermore, our study provides important information for the discovery of novel biomarkers and therapeutic targets in the management of cardiorenal syndrome.

摘要

背景

动静脉瘘(AVF)是需要血液透析患者血管通路的金标准,但可能会给心血管系统带来额外的血液动力学压力。心脏、肾脏和 AVF 之间的复杂相互作用仍不完全清楚。

方法和结果

我们构建了一个新的六分之五部分肾切除术(NX)和动静脉瘘大鼠模型。NX 导致尿素、肌酐和马尿酸增加。添加动静脉瘘(AVF+NX)进一步增加了尿素和一些尿毒症毒素,如三甲胺氧化物,并导致心指数、左右心室容积和右心室质量增加。尿毒症毒素的血浆水平与心室形态和功能密切相关。心脏转录组学鉴定出 NX 后有 8 个基因和 AVF+NX 后有 894 个基因的表达发生改变,而肾脏转录组学分别有 290 个和 1431 个基因发生改变。基因本体论和京都基因与基因组百科全书分析显示,两个器官的基因表达变化与细胞分裂和免疫激活有关,心脏的核糖体和转录活性受到抑制,肾脏的肾素-血管紧张素信号和chronodisruption 发生改变。除后者外,AVF+NX 比 NX 中的改变更为严重。

结论

动静脉瘘造瘘后,慢性肾脏病的炎症和器官功能障碍加重。此外,我们的研究为发现心脏肾综合征管理中的新型生物标志物和治疗靶点提供了重要信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3beb/9673660/7ddf722136bf/JAH3-11-e027593-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3beb/9673660/1d43e820f4ec/JAH3-11-e027593-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3beb/9673660/f7549d6b1d53/JAH3-11-e027593-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3beb/9673660/5fa62b4b762f/JAH3-11-e027593-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3beb/9673660/5b55ded350a3/JAH3-11-e027593-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3beb/9673660/5effe6c38053/JAH3-11-e027593-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3beb/9673660/a90bf49a03b1/JAH3-11-e027593-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3beb/9673660/95ededee917b/JAH3-11-e027593-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3beb/9673660/f5a4d3ded6b9/JAH3-11-e027593-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3beb/9673660/0e3738370923/JAH3-11-e027593-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3beb/9673660/1ebd05393a0f/JAH3-11-e027593-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3beb/9673660/7ddf722136bf/JAH3-11-e027593-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3beb/9673660/1d43e820f4ec/JAH3-11-e027593-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3beb/9673660/f7549d6b1d53/JAH3-11-e027593-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3beb/9673660/5fa62b4b762f/JAH3-11-e027593-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3beb/9673660/5b55ded350a3/JAH3-11-e027593-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3beb/9673660/5effe6c38053/JAH3-11-e027593-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3beb/9673660/a90bf49a03b1/JAH3-11-e027593-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3beb/9673660/95ededee917b/JAH3-11-e027593-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3beb/9673660/f5a4d3ded6b9/JAH3-11-e027593-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3beb/9673660/0e3738370923/JAH3-11-e027593-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3beb/9673660/1ebd05393a0f/JAH3-11-e027593-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3beb/9673660/7ddf722136bf/JAH3-11-e027593-g011.jpg

相似文献

1
Arteriovenous Fistulae in Chronic Kidney Disease and the Heart: Physiological, Histological, and Transcriptomic Characterization of a Novel Rat Model.慢性肾脏病和心脏中的动静脉瘘:一种新型大鼠模型的生理学、组织学和转录组学特征。
J Am Heart Assoc. 2022 Oct 18;11(20):e027593. doi: 10.1161/JAHA.122.027593. Epub 2022 Oct 7.
2
The impact of location and patency of the arteriovenous fistula on quality of life of kidney transplant recipients.动静脉瘘的位置和通畅情况对肾移植受者生活质量的影响。
Ren Fail. 2021 Dec;43(1):113-122. doi: 10.1080/0886022X.2020.1865171.
3
Right Ventricular Enlargement within Months of Arteriovenous Fistula Creation in 2 Hemodialysis Patients.2例血液透析患者动静脉内瘘建立后数月内出现右心室扩大
Tex Heart Inst J. 2016 Aug 1;43(4):350-3. doi: 10.14503/THIJ-15-5353. eCollection 2016 Aug.
4
Factors associated with functional arteriovenous fistula at hemodialysis start and arteriovenous fistula non-use in a single-center cohort.在单中心队列中,与血液透析开始时功能性动静脉瘘及动静脉瘘未使用相关的因素。
J Vasc Access. 2022 Jul;23(4):558-566. doi: 10.1177/11297298211002574. Epub 2021 Mar 22.
5
Comparison of Ellipsys Percutaneous and Proximal Forearm Gracz-Type Surgical Arteriovenous Fistulas.Ellipsys经皮与前臂近端Gracz型手术动静脉内瘘的比较
Am J Kidney Dis. 2021 Oct;78(4):520-529.e1. doi: 10.1053/j.ajkd.2021.01.011. Epub 2021 Mar 1.
6
Mitochondrial targeted catalase improves muscle strength following arteriovenous fistula creation in mice with chronic kidney disease.线粒体靶向过氧化氢酶可改善慢性肾脏病小鼠动静脉瘘造瘘术后的肌肉力量。
Sci Rep. 2024 Apr 9;14(1):8288. doi: 10.1038/s41598-024-58805-1.
7
Medicare Costs Associated With Arteriovenous Fistulas Among US Hemodialysis Patients.美国血液透析患者动静脉瘘相关的医疗保险费用。
Am J Kidney Dis. 2018 Jul;72(1):10-18. doi: 10.1053/j.ajkd.2018.01.034. Epub 2018 Mar 28.
8
[Vascular access in diabetic patients. Are these patients "difficult"?].[糖尿病患者的血管通路。这些患者“难处理”吗?]
Postepy Hig Med Dosw (Online). 2015 Aug 11;69:913-7. doi: 10.5604/17322693.1164430.
9
Metabolomic profiling reveals muscle metabolic changes following iliac arteriovenous fistula creation in mice.代谢组学分析揭示了小鼠髂动静脉瘘造瘘术后肌肉代谢的变化。
Am J Physiol Renal Physiol. 2022 Nov 1;323(5):F577-F589. doi: 10.1152/ajprenal.00156.2022. Epub 2022 Aug 25.
10
International Differences in the Location and Use of Arteriovenous Accesses Created for Hemodialysis: Results From the Dialysis Outcomes and Practice Patterns Study (DOPPS).国际间血液透析用动静脉通路位置与使用的差异:来自透析结局和实践模式研究(DOPPS)的结果。
Am J Kidney Dis. 2018 Apr;71(4):469-478. doi: 10.1053/j.ajkd.2017.09.012. Epub 2017 Dec 1.

引用本文的文献

1
The rodent models of arteriovenous fistula.动静脉瘘的啮齿动物模型。
Front Cardiovasc Med. 2024 Jan 18;11:1293568. doi: 10.3389/fcvm.2024.1293568. eCollection 2024.
2
Metabolomics Assessment of Volume Overload-Induced Heart Failure and Oxidative Stress in the Kidney.容量超负荷诱导的心力衰竭和肾脏氧化应激的代谢组学评估
Metabolites. 2023 Nov 20;13(11):1165. doi: 10.3390/metabo13111165.

本文引用的文献

1
Intestinal barrier dysfunction is associated with elevated right atrial pressure in patients with advanced decompensated heart failure.肠屏障功能障碍与晚期失代偿性心力衰竭患者的中心静脉压升高有关。
Am Heart J. 2022 Mar;245:78-80. doi: 10.1016/j.ahj.2021.11.014. Epub 2021 Dec 18.
2
Association of Trimethylamine-N-Oxide Levels with Risk of Cardiovascular Disease and Mortality among Elderly Subjects: A Systematic Review and Meta-Analysis.三甲胺氮氧化物水平与老年人群心血管疾病风险和死亡率的关联:系统评价和荟萃分析。
Cardiorenal Med. 2022;12(2):39-54. doi: 10.1159/000520910. Epub 2021 Dec 16.
3
Effects of Microbiota-Driven Therapy on Circulating Indoxyl Sulfate and P-Cresyl Sulfate in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
肠道菌群移植对慢性肾脏病患者循环吲哚硫酸酯和对甲酚硫酸酯的影响:一项随机对照试验的系统评价和荟萃分析。
Adv Nutr. 2022 Aug 1;13(4):1267-1278. doi: 10.1093/advances/nmab149.
4
Inhibition of the renin-angiotensin system causes concentric hypertrophy of renal arterioles in mice and humans.肾素-血管紧张素系统的抑制会导致小鼠和人类肾小动脉的向心性肥大。
JCI Insight. 2021 Dec 22;6(24):e154337. doi: 10.1172/jci.insight.154337.
5
Heterogenous Role of IRF4 in Kidney Fibrosis.IRF4在肾纤维化中的异质性作用。
J Am Soc Nephrol. 2021 Nov;32(11):2971-2972. doi: 10.1681/ASN.2021060835. Epub 2021 Oct 5.
6
clusterProfiler 4.0: A universal enrichment tool for interpreting omics data.clusterProfiler 4.0:用于解释组学数据的通用富集工具。
Innovation (Camb). 2021 Jul 1;2(3):100141. doi: 10.1016/j.xinn.2021.100141. eCollection 2021 Aug 28.
7
Autocrine and paracrine effects of a novel podocyte gene, RARRES1.新型足细胞基因 RARRES1 的自分泌和旁分泌作用。
Kidney Int. 2021 Oct;100(4):745-747. doi: 10.1016/j.kint.2021.07.008.
8
Clec4e-Receptor Signaling in Myocardial Repair After Ischemia-Reperfusion Injury.Clec4e受体信号在缺血再灌注损伤后心肌修复中的作用
JACC Basic Transl Sci. 2021 Aug 23;6(8):631-646. doi: 10.1016/j.jacbts.2021.07.001. eCollection 2021 Aug.
9
Intestinal Barrier Dysfunction Exacerbates Neuroinflammation via the TLR4 Pathway in Mice With Heart Failure.肠道屏障功能障碍通过Toll样受体4途径加剧心力衰竭小鼠的神经炎症。
Front Physiol. 2021 Aug 6;12:712338. doi: 10.3389/fphys.2021.712338. eCollection 2021.
10
Cardio-renal benefits of sodium-glucose co-transporter 2 inhibitors in heart failure with reduced ejection fraction: mechanisms and clinical evidence.钠-葡萄糖协同转运蛋白2抑制剂对射血分数降低的心力衰竭患者的心肾益处:作用机制与临床证据
Eur Heart J Cardiovasc Pharmacother. 2022 May 5;8(3):311-321. doi: 10.1093/ehjcvp/pvab056.